'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease

Schaan, Beatriz D.; Quadros, Alexandre S.; Sarmento-Leite, Rogério; De Lucca, Jr., Giuseppe; Bender, Alexandra; Bertoluci, Marcello
January 2007
Cardiovascular Diabetology;2007, Vol. 6, p19
Academic Journal
Background: The association between TGF- β1 levels and long-term major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) is controversial. No study specifically addressed patients with CAD and diabetes mellitus (DM). The association between TGF- β1 levels and long-term major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) is controversial. No study specifically addressed patients with CAD and diabetes mellitus (DM). Methods: Patients (n = 135, 30-80 years) referred for coronary angiography were submitted to clinical and laboratory evaluation, and the coronary angiograms were evaluated by two operators blinded to clinical characteristics. CAD was defined as the presence of a 70% stenosis in one major coronary artery, and DM was characterized as a fasting glycemia > 126 mg/dl or known diabetics (personal history of diabetes or previous use of anti-hyperglycemic drugs or insulin). Based on these criteria, study patients were classified into four groups: no DM and no CAD (controls, C n = 61), DM without CAD (D n = 23), CAD without DM (C-CAD n = 28), and CAD with DM (D-CAD n = 23). Baseline differences between the 4 groups were evaluated by the χ ² test for trend (categorical variables) and by ANOVA (continuous variables, post-hoc Tukey). Patients were then followed-up during two years for the occurrence of MACE (cardiac death, stroke, myocardial infarction or myocardial revascularization). The association of candidate variables with the occurrence of 2-year MACE was assessed by univariate analysis. Results: The mean age was 58.2 ± 0.9 years, and 51% were men. Patients with CAD had a higher mean age (p = 0.011) and a higher percentage were male (p = 0.040). There were no significant baseline differences between the 4 groups regarding hypertension, smoking status, blood pressure levels, lipid levels or inflammatory markers. TGF-β1 was similar between patients with or without CAD or DM (35.1 ×/÷ 1.3, 33.6 ×/÷ 1.6, 33.9 ×/÷ 1.4 and 31.8 ×/÷ 1.4 ng/ml in C, D, C-CAD and D-CAD, respectively, p = 0.547). In the 2-year follow-ip, independent predictors of 2-year MACE were age (p = 0.007), C-reactive protein (p = 0.048) and systolic blood pressure (p = 0.008), but not TGF-β1. Conclusion: Serum TGF-β1 was not associated with CAD or MACE occurrence in patients with or without DM.


Related Articles


    An unusual case of associated cardiovascular disease is presented. A 64-yearold diabetic, arterioselerotic and hypertensive patient had an episode of pulmonary edema with vascular collapse followed by bilateral gangrene of the lower limbs. A second episode caused death. Autopsy revealed: (1)...

  • Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: A prospective study in 716 patients over 8 years. Becker, Alexander; Leber, Alexander W.; Becker, Christoph; von Ziegler, Franz; Tittus, Janine; Schnoeder, Ines; Steinbeck, Gerhard; Knez, Andreas // BMC Cardiovascular Disorders;2008, Vol. 8, Special section p1 

    Background: To establish an efficient prophylaxis of coronary artery disease reliable risk stratification is crucial, especially in the high risk population of patients suffering from diabetes mellitus. This prospective study determined the predictive value of coronary calcifications for future...

  • Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Wu, Yang; Xia, Zhong-yuan; Dou, Juan; Zhang, Li; Xu, Jin-jin; Zhao, Bo; Lei, Shaoqing; Liu, Hui-min // Molecular Biology Reports;Oct2011, Vol. 38 Issue 7, p4327 

    The objective of the current study is to investigate whether ginsenoside Rb1, a major pharmacological extract of ginseng that could attenuate myocardial ischemia reperfusion (MI/R) injury in non-diabetic myocardium, can attenuate MI/R injury in diabetes that are more vulnerable to ischemic...

  • Coronary Artery Disease -- Myocardial Infarction.  // Current Medical Literature: Interventional Cardiology Monitor;2006, Vol. 13 Issue 2, p47 

    Presents abstracts of studies on myocardial infarction. "Occurrence of Non-Q Wave Myocardial Infarction Following Percutaneous Coronary Intervention in the Stent Era: Systematic Monitoring of the Three Markers of Myocardial Infarction," by E. Varani et al, published in a 2005 issue of the...

  • Impact of diabetes mellitus on long term survival after acute myocardial infarction in patients with single vessel disease. Ishihara, M.; Sato, H.; Kawagoe, T.; Shimatani, Y.; Kurisu, S.; Nishioka, K.; Kouno, Y.; Umemura, T.; Nakamura, S. // Heart;Aug2001, Vol. 86 Issue 2, p133 

    Objective-To assess the influence of diabetes on long term prognosis after reperfusion treatment and its interaction with multivessel disease. Design-A retrospective observational study. Setting-Hiroshima City Hospital. Patients-i 660 consecutive patients with acute myocardial infarction who...

  • Is it an AMI or not? Get the whole story.  // ED Nursing;Apr2010, Vol. 13 Issue 6, p63 

    The article presents suggestions by various medical practitioners regarding medical care of patients with myocardial infarction. Cathy C. Fox, clinical nurse educator says that the patient's color and skin should be examined in case of high respiratory rate. Clinical educator Tracy Simmons says...

  • Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Hanefeld, Markolf; Koehler, Carsta; Gallo, Silvina; Benke, Inge; Ott, Petra // Cardiovascular Diabetology;2007, Vol. 6, p13 

    Background: One of the major controversies surrounding the metabolic syndrome (MetS) in type 2 diabetes is whether its single components act synergistically as risk factors for atherosclerotic vascular disease (AVD). We aimed to answer this by evaluating the relationship, and its various...

  • Association of Mycoplasma pneumoniae Infection with Myocardial Infarction. Pourahmad, Morteza; Jahromy, Abdolreza Sotoodeh; Shojaei, Mohammad // American Journal of Immunology;2009, Vol. 5 Issue 3, p84 

    Problem statement: In addition to the major risk factors for atherosclerosis such as high plasma level of low density lipoprotein, low plasma level of high density lipoprotein, cigarette smoking, hypertension and diabetes mellitus, some studies introduce other agents such as Mycoplasma...

  • Treatment after acute MI in diabetics. Hoekzema, Grant S. // Journal of Family Practice;Sep1997, Vol. 45 Issue 3, p201 

    This article presents a study which examined whether intensive insulin therapy after acute myocardial infarction (MI) improve long-term survival in patients with diabetes mellitus. The primary study endpoint was the long-term all-cause mortality. Intravenous infusion of insulin-glucose...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics